Pharma news
Pharma
Novo Nordisk has bought a University of Bristol spin-out company for $800 million, in a deal which could transform the way diabetes is treated. 20 August 2018
Americas
Mike Young was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 20 August 2018
Pharma
Alisa Harbin was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports. 17 August 2018
Americas
The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions. 17 August 2018
Americas
Pfizer has entered into a multi-year collaboration with immunotherapy company BioNTech to develop messenger ribonucleic acid-based vaccines for influenza. 16 August 2018
Americas
Padmanabh Bhatt was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 15 August 2018
Americas
A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end. 15 August 2018
Pharma
Following a CJEU decision in July, and with two more cases on the horizon, Joel Beevers and Michael Pears of Potter Clarkson report on whether an active ingredient (or combination of active ingredients) is ‘protected by a basic patent’, as required for a supplementary protection certificate. 14 August 2018
Americas
Members of the Pharmaceutical Research and Manufacturers of America last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development. 13 August 2018
Asia-Pacific
South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence. 10 August 2018